The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
968
February 16, 1996
View Complete Issue         Table of Contents 2019 
Issue 968
Subscribers: Log in to read full issue.  Not a subscriber?  Subscribe or purchase issue.
Nisoldipine-A New Calcium-Channel Blocker for Hypertension
February 16, 1996 (Issue: 968)
Nisoldipine (Sular -Zeneca), a dihydropyridine calcium-channel blocker structurally similar to nifedipine, has been approved for marketing by the US Food and Drug Administration. It is available in an oral extended-release formulation for treatment...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this issue?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App
  • FREE online per issue CME/CE
Purchase this issue:
Title: Issue 968
 


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.